热血球蛋白结合和特异性的批量变化和患者异质性:一种尺寸不适合所有人
Nicoline H M den Hollander1, Diahann T S L Jansen1, Bart O Roep1
1Department of Internal Medicine, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Journal of clinical medicine
|January 25, 2025
概括
甲基球蛋白批量变异性影响免疫细胞结合和细胞因子释放,这可能解释了1型糖尿病治疗中的不同患者反应. 个性化剂量可能会改善结果.
科学领域:
- 免疫学 免疫学 免疫学
- 移植科学 移植科学
- 内分泌学 在内分泌学.
背景情况:
- 用于预防异体移植排斥的胸球蛋白,正在研究用于1型糖尿病免疫疗法.
- 它包括子抗体,准人体胆小细胞和白细胞,由于其生产方法,可能会因批量而异.
研究的目的:
- 为了比较不同批次的抗体组成和与外围血液单核细胞 (PBMC) 和T细胞子集结合的个体间差异.
- 为了评估由Thymoglobulin诱导的细胞因子产生及其可变性.
主要方法:
- 结合了四批红血球蛋白,并用于染色来自健康捐赠者的PBMC.
- 流细胞计分析了与PBMC和T细胞子集的结合.
- 细胞因子诱导是在全血中测量的,全血与Thymoglobulin进行化.
主要成果:
- 胸球蛋白与所有PBMC亚群结合,包括调节性T细胞.
- 结合显示出高的个体间变异性和中度的批量差异.
- 与细胞因子释放综合征相关的细胞因子在所有捐赠者和批次中变化增加.
结论:
- 甲基球蛋白结合和细胞因子反应的个体间变异可能解释不同的临床结果.
- 建议进行个性化剂量调整,以优化疗效并最大限度地降低胆固醇蛋白治疗的不良影响.
更多相关视频
13:14Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood
Published on: February 6, 2018
10.3K
06:15Characterization of Thymus-dependent and Thymus-independent Immunoglobulin Isotype Responses in Mice Using Enzyme-linked Immunosorbent Assay
Published on: September 7, 2018
9.4K
相关概念视频
Special Features of Adaptive Immunity
The adaptive immune system, a crucial component of the overall immune response, offers a highly specialized defense against pathogens. It involves specific cell types and features, enabling it to combat infections effectively and efficiently.
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
The primary cell types involved in adaptive immunity are T cells and B cells. Each type has a unique role in defending the body against pathogens. T cells are responsible for cell-mediated immunity. They identify and eliminate infected cells directly,...
Factors Affecting Protein-Drug Binding: Patient-Related Factors
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Dosage Regimen: Individualization
Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...
